Investigating how synthetic mucins interact with viruses
Synthetic mucins in epithelial models to probe virus-mucin interactions
This study is all about creating lab-made substances that act like the natural protective barriers in our bodies, helping researchers learn how viruses stick to and invade our cells, which could lead to better ways to prevent infections.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Utah NIH-funded |
| Lab location | 1 site (Salt Lake City, United States) |
| Project ID | NIH-11044912 on NIH RePORTER |
What this research studies
This research focuses on developing synthetic mucins, which are designed to mimic the natural mucins found in the human body. These synthetic mucins will be used in engineered models to study how viruses interact with mucins, which play a crucial role in protecting epithelial cells from infections. By understanding these interactions, researchers aim to uncover how viruses adhere to and penetrate host cells, potentially leading to new strategies for preventing viral infections. The study employs advanced techniques to create and analyze these mucin models, providing insights into their biological functions and applications in health and disease.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with conditions that affect epithelial tissues, such as respiratory infections or gastrointestinal disorders.
Not a fit: Patients with non-epithelial related conditions or those not affected by viral infections may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved strategies for preventing and treating viral infections.
How similar studies have performed: Other research has shown promise in using mucin models to study viral interactions, indicating that this approach could yield valuable insights.
Where this research is happening
Salt Lake City, United States
- University of Utah — Salt Lake City, United States (Active)
Researchers
- Principal investigator: Kramer, Jessica — University of Utah
- Study coordinator: Kramer, Jessica
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.